Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

(2010) E C Dijkers et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

(2010) J. Löfblom et al.   FEBS LETTERS

Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules

(2010) R. P. Baum et al.   JOURNAL OF NUCLEAR MEDICINE

In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass

(2010) Irina Velikyan et al.   NUCLEAR MEDICINE AND BIOLOGY

Quantitative analysis of PET studies

(2010) Wolfgang A. Weber   RADIOTHERAPY AND ONCOLOGY

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount

(2009) Vladimir Tolmachev et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules

(2009) G. Kramer-Marek et al.   JOURNAL OF NUCLEAR MEDICINE

Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine

(2009) S. Ahlgren et al.   JOURNAL OF NUCLEAR MEDICINE

HER-2/neu expression in primary and metastatic breast cancer

(2008) Elyse E. Lower et al.   BREAST CANCER RESEARCH AND TREATMENT

Slow Internalization of Anti-HER2 Synthetic Affibody Monomer 111In-DOTA-ZHER2:342-pep2 : Implications for Development of Labeled Tracers

(2008) Helena Wållberg et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Alternative binding proteins: Affibody binding proteins developed from a small three-helix bundle scaffold

(2008) Per-Åke Nygren   FEBS Journal

Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using 111In-J591: Lesion Detectability and Dosimetric Projections for 90Y Radioimmunotherapy

(2008) N. Pandit-Taskar et al.   JOURNAL OF NUCLEAR MEDICINE

Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with Site-Specific 18F-Labeled Protein Scaffold Molecules

(2008) Z. Cheng et al.   JOURNAL OF NUCLEAR MEDICINE

The importance of high specific radioactivity in the performance of 68Ga-labeled peptide

(2008) Irina Velikyan et al.   NUCLEAR MEDICINE AND BIOLOGY

Drug Insight: intracellular inhibitors of HER2—clinical development of lapatinib in breast cancer

(2008) David A Cameron et al.   Nature clinical practice. Oncology